ストックスクリーナーアプリを入手
58.73
2.04%
-1.22
前日終値:
$59.95
開ける：
$59.71
24時間の取引高:
1.51M
Relative Volume:
1.05
時価総額：
$9.65B
収益：
$1.17B
当期純損益:
$150.71M
株価収益率:
62.48
EPS:
0.94
ネットキャッシュフロー:
$245.03M
1週間 パフォーマンス:
-3.10%
1か月 パフォーマンス:
-4.08%
6か月 パフォーマンス:
-25.39%
1年 パフォーマンス:
-16.56%
1日の値動き範囲:
$58.47
$59.88
1週間の範囲:
$58.47
$62.15
52週間の値動き範囲:
$56.60
$85.57
Bio Techne Corp Stock (TECH) Company Profile
TECH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
58.73 | 9.65B | 1.17B | 150.71M | 245.03M | 0.94 |
|
VRTX
Vertex Pharmaceuticals Inc
|
492.69 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
637.36 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
589.15 | 35.93B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
268.46 | 34.75B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
267.39 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Bio Techne Corp Stock (TECH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-18 | 開始されました | Evercore ISI | Outperform |
| 2025-02-19 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-05-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-02-08 | 開始されました | Scotiabank | Sector Outperform |
| 2024-02-02 | ダウングレード | Stifel | Buy → Hold |
| 2023-12-07 | 開始されました | UBS | Buy |
| 2023-08-28 | 開始されました | William Blair | Outperform |
| 2023-01-10 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | 開始されました | Deutsche Bank | Buy |
| 2022-12-12 | アップグレード | Citigroup | Neutral → Buy |
| 2022-12-07 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-04-25 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | アップグレード | Stifel | Hold → Buy |
| 2021-01-25 | 繰り返されました | The Benchmark Company | Buy |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 開始されました | Atlantic Equities | Overweight |
| 2020-07-15 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | ダウングレード | Stifel | Buy → Hold |
| 2020-05-14 | 開始されました | The Benchmark Company | Buy |
| 2020-01-08 | 再開されました | Stephens | Overweight |
| 2020-01-08 | 開始されました | Wells Fargo | Equal Weight |
| 2020-01-07 | 開始されました | Citigroup | Neutral |
| 2019-11-15 | 開始されました | Stifel | Buy |
| 2019-07-02 | アップグレード | Janney | Neutral → Buy |
| 2019-01-14 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | ダウングレード | Craig Hallum | Buy → Hold |
| 2018-10-17 | 開始されました | Goldman | Neutral |
| 2018-06-15 | 開始されました | Argus | Buy |
| 2017-07-13 | 開始されました | Wells Fargo | Market Perform |
| 2017-02-09 | 開始されました | Citigroup | Buy |
| 2017-01-18 | 開始されました | Deutsche Bank | Buy |
| 2016-11-10 | 再開されました | Leerink Partners | Outperform |
| 2015-01-21 | 繰り返されました | Robert W. Baird | Outperform |
| 2013-09-20 | アップグレード | Robert W. Baird | Neutral → Outperform |
すべてを表示
Bio Techne Corp (TECH) 最新ニュース
Research Tools & Consumables Stocks Q4 Earnings: Bio-Techne (NASDAQ:TECH) Best of the Bunch - Yahoo Finance
Bio-Techne to Open New Customer Facility in Germany - Marketscreener.com
Bio-Techne's New Tech Hub Targets Major European Life Sciences Growth - StockTitan
Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting - Lelezard
Game-Changing Cancer Detection Technology: RNAscope Shows Superior Results in Multiple Tumors - StockTitan
Bio-Techne Earnings Preview: What to Expect - MSN
Evercore ISI Group Initiates Coverage of Bio-Techne (TECH) with Outperform Recommendation - MSN
Evercore ISI sets Bio-Techne stock Outperform with $75 target By Investing.com - Investing.com South Africa
6 Analysts Assess Bio-Techne: What You Need To Know - Benzinga
Evercore ISI sets Bio-Techne stock Outperform with $75 target - Investing.com
Bio-Techne: A Premium Growth Asset with Strong Market Position and Promising Future - TipRanks
Bio-Techne (NASDAQ:TECH) shareholders have earned a 8.3% CAGR over the last five years - Yahoo Finance
Bio-Techne Co. (NASDAQ:TECH) Receives $82.14 Consensus Price Target from Analysts - Defense World
Complement C4 Antibody Market Research 2025: Growing Focus on Precision Medicine and Targeted Therapies, and Increasing Investment in Immunotherapies and Biologic Drugs - GlobeNewswire Inc.
Bio Techne at Barclays Conference: Strategic Growth Amid Market Challenges - Investing.com
TECH Stock Might Rise Following the Leo Shipping Announcement - Nasdaq
Bio-Techne Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Bio-Techne at Leerink’s Global Healthcare Conference: Strategic Growth Amid Challenges - Investing.com India
Techne Corp stock hits 52-week low at $58.94 amid market shifts - Investing.com India
Techne Corp stock hits 52-week low at $58.94 amid market shifts By Investing.com - Investing.com South Africa
GC Wealth Management RIA LLC Takes $805,000 Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Bio-Techne Corp (TECH) Q1 FY2025 Earnings: Revenue Surpasses Est - GuruFocus.com
Bio-Techne Begins Shipping LeoA Next Generation High-Throughput Simple Western System - Quantisnow
Bio-Techne launches high-throughput Leo System - Investing.com
Bio-Techne's New Leo System Revolutionizes Protein Analysis Speed - StockTitan
Bio-Techne Corp. to Host Earnings Call - ACCESS Newswire
(TECH) Trading Advice - Stock Traders Daily
Techne (TECH) Down 15.5% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Citigroup Has Lowered Expectations for Bio-Techne (NASDAQ:TECH) Stock Price - Defense World
Y Intercept Hong Kong Ltd Makes New Investment in Bio-Techne Co. (NASDAQ:TECH) - Defense World
Bio-Techne to pay $37M to former CEO after arbitration By Investing.com - Investing.com South Africa
Bio-Techne to pay $37M to former CEO after arbitration - Investing.com
TECH Joins Forces With Oxford Nanopore Technologies: Stock to Gain? - Yahoo Finance
TECHBio-Techne Corp Latest Stock News & Market Updates - StockTitan
Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes - Yahoo Finance
Can This New Bio-Techne Genetic Panel Solve What Other Technologies Cannot? - StockTitan
Ieq Capital LLC Lowers Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Handelsbanken Fonder AB Has $3.19 Million Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Bio-Techne Co. (NASDAQ:TECH) Shares Sold by Principal Financial Group Inc. - MarketBeat
Fjarde AP Fonden Fourth Swedish National Pension Fund Lowers Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Weitz Partners III Opportunity Fund Added Bio-Techne Corporation (TECH) to its Portfolio - Yahoo Canada Finance
Is the Market Bullish or Bearish on Bio-Techne? - Benzinga
Bio-Techne Co. (NASDAQ:TECH) Shares Acquired by Hahn Capital Management LLC - MarketBeat
Bank of New York Mellon Corp Sells 11,006 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Truist Financial Corp Cuts Stock Holdings in Bio-Techne Co. (NASDAQ:TECH) - Defense World
Techne Corp stock hits 52-week low at $61.16 amid market shifts - Investing.com Canada
Techne Corp stock hits 52-week low at $61.16 amid market shifts By Investing.com - Investing.com South Africa
Gene Prediction Tools Market Analysis Report 2025-2030, with Bio-Techne, Charles River Laboratories, Eurofins, GenScript, Danaher, MedGenome, Sino Biological, Syngene & Twist Bioscience - Yahoo Finance
How CI&T's AI-Powered Development Platform Earned Top Forrester Recognition - StockTitan
Bio-Techne Stock Set to Benefit From Expansion of RNAscope Menu - MSN
Capillary Electrophoresis Market Report 2025-2030, with Profiles of Bio-Rad Laboratories, Bio-Techne, Qiagen, Helena Laboratories, Agilent Technologies, PerkinElmer, Danaher, Merck, Shimadzu & more - Yahoo Finance
Bio Techne Corp (TECH) 財務データ
収益
当期純利益
現金流量
EPS
Bio Techne Corp (TECH) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Herr Amy E. | Director |
Feb 14 '25 |
Sale |
65.96 |
1,860 |
122,691 |
1,976 |
0.39%
0.34%
大文字化:
|
ボリューム (24 時間):